Agenda

The agenda features a mix of clinical updates and lively debates on provocative scientific topics impacting the field, including emerging concepts and therapies in multiple myeloma, lymphoma, acute and chronic lymphocytic leukemia, myeloid malignancies, and much more.

The 2023 scientific agenda will be available shortly. Check back soon for updates.

Highlights

Lymphoma
Chronic Lymphocytic Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia/ Myelodysplastic Syndrome
Multiple Myeloma

Engaging Debates

CNS Prophylaxis in Aggressive Lymphoma - Aggressive/ Futile
Should MRD+ Patients with AML Proceed with HSCT? Yes / No
Will ASCT Continue to Be the Standard of Care in Frontline Therapy? Yes / No

Bonus Sessions (On-demand)

Quality of Life and Survivorship in Lymphoma Patient
What Is the Future of ctDNA in Lymphoma ?
Chemo-free or Chemo-light Approaches to the Treatment of ALL
Help! Making Sense of the ICC/ELN Classifications and Where Do They Fit with the WHO? What Should the Practicing Hematologist/Oncologist Be Aware Of?
Update on CNL and CMMoL
The Future of Myeloma
Health Disparity in Multiple Myeloma and How to Overcome It in the Clinic